Copyright
©The Author(s) 2020.
World J Clin Oncol. Jun 24, 2020; 11(6): 397-404
Published online Jun 24, 2020. doi: 10.5306/wjco.v11.i6.397
Published online Jun 24, 2020. doi: 10.5306/wjco.v11.i6.397
Table 3 Immunological response: statistical analysis
| Mean (standard deviation) baseline | Median (interquartile range) baseline | Mean (standard deviation) 30 d after HIPEC | Median (interquartile range) 30 d after HIPEC | Unilateral paired Student t test | P value | |
| CD3+ | 1040.0 (± 165.8) | 1007.0 (912.0–1228.0) | 2002.3 (± 1364.4) | 1705.5 (1335.0–2304.0) | -1.75 | 0.07 |
| CD3+/CD4+ T helper | 888.7 (± 360.8) | 825.0 (602.0–1075.0) | 1184.2 (± 649.7) | 1139.5 (835.0–1443.0) | -2.05 | 0.048 |
| CD3+/CD8+ T cytotoxic | 501.0 (± 600.9) | 264.0 (158.0–473.0) | 782.2 (± 733.6) | 595.5 (290.0–846.0) | -2.05 | 0.048 |
| CD3-/CD56+ NK | 217.5 (± 144.9) | 203.5 (141.0–238.0) | 334.2 (± 208.9) | 377.5 (116.0–501.0) | -1.69 | 0.07 |
| CD19+ B lymphocytes | 142.7 (± 54.2) | 142.0 (129.0–152.0) | 184.5 (± 155.1) | 144.5 (78.0–184.0) | -0.67 | 0.26 |
| CD4/CD8 ratio | 3.3 (± 2.3) | 3.0 (1.0–5.0) | 2.2 (± 1.0) | 2.0 (2.0–2.0) | 1.78 | 0.07 |
- Citation: Fiorentini G, Sarti D, Patriti A, Eugeni E, Guerra F, Masedu F, Mackay AR, Guadagni S. Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: A pilot study. World J Clin Oncol 2020; 11(6): 397-404
- URL: https://www.wjgnet.com/2218-4333/full/v11/i6/397.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i6.397